StockData
Adagene Inc. logo

Adagene Inc. (ADAG) stock

ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 5/30
$1.82+0.34 (+22.97%)

Close on Nov 18, 2026Market cap $107.80MP/E –Yield –

Adagene net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -$17.61M. The highest annual figure on record is -$15.27M in fiscal 2018.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$17.61M–
FY2024Dec 31, 2024-$33.42M–
FY2023Dec 31, 2023-$18.95M–
FY2022Dec 31, 2022-$79.97M–
FY2021Dec 31, 2021-$73.18M–
FY2020Dec 31, 2020-$42.40M–
FY2019Dec 31, 2019-$16.43M–
FY2018Dec 31, 2018-$15.27M–

More Adagene figures

See a number that looks wrong?